More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches New Website

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches New Website

by adminAdrianRamirez | Feb 2, 2017 | HempMeds Brasil, Press Releases

SAN DIEGO, Feb. 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds Brasil™ has launched a new website featuring brand information, a navigable web...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of RSHO™ Green Label Into Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of RSHO™ Green Label Into Brazil

by adminAdrianRamirez | Feb 1, 2017 | HempMeds Brasil, Press Releases

AN DIEGO, Feb. 1, 2017  — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green...
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit

by adminAdrianRamirez | Jan 31, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Jan. 31, 2017  — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import...
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Launches New Website

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Launches New Website

by adminAdrianRamirez | Jan 30, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Jan. 30, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico has launched its new website, featuring a fresh interface,...
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of a New Product- “Kannaway® Gold Premium Hemp Oil”

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of a New Product- “Kannaway® Gold Premium Hemp Oil”

by adminAdrianRamirez | Jan 25, 2017 | Kannaway, Press Releases

New Hemp Oil Product is Company’s Highest Potency Product and is Available Now in 15-gram Tube SAN DIEGO, Jan. 25, 2017 /PRNewswire/ — Medical Marijuana, Inc. MJNA, +6.62%announced today that its subsidiary Kannaway®, LLC, the first hemp lifestyle network...
Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

by adminAdrianRamirez | Jan 24, 2017 | HempMeds Mexico, Press Releases

Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, Jan. 24, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.